Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 938 (LINC00938) is a human long non-coding RNA (lncRNA) gene located on chromosome 8 and does not code for a protein[1][5][6]. It is classified as an intergenic lncRNA and has been implicated through bioinformatic analyses in biological processes including gene regulation, cilium morphogenesis, and skin development[3][4]. LINC00938 is downregulated in breast cancer tissues and identified as a possible tumor suppressor lncRNA[2]. It is also suggested to serve as a biomarker for prognosis in both breast cancer and non-small cell lung cancer, based on expression signatures, but its precise molecular mechanism remains to be experimentally validated[2][4]. There are currently no known drugs targeting it directly, and its therapeutic relevance is limited to its investigational role as a biomarker rather than a proven actionable target[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 938 (LINC00938).